Iris Hoxha - Concepedia

Author

Iris Hoxha

University of Medicine Tirana

Also Known As

Andi Koraqi, Hoxha, Iris, Iris Hoxha, Islam, Salequl

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

University of Medicine Tirana University of Strathclyde Health Insurance Institute of Slovenia University of Banja Luka Sefako Makgatho Health Sciences University

About

Iris Hoxha is an author at University of Medicine Tirana specializing in antimicrobial resistance, preventive medicine, and antimicrobial stewardship.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	86
2	Public Health	2	2	86
3	Health Sciences	1	1	18
4	Global Health	1	1	68
5	Health Policy	1	1	18

Iris Hoxha

Publications

Citations

H-Index

Page 1

	Year	Citations
Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey Ann Versporten, Peter Zarb, Isabelle Caniaux, The Lancet Global Health	2018	656
Use of the WHO Access, Watch, and Reserve classification to define patterns of hospital antibiotic use (AWaRe): an analysis of paediatric survey data from 56 countries Yingfen Hsia, Brian Lee, Ann Versporten, The Lancet Global Health	2019	352
Ongoing strategies to improve the management of upper respiratory tract infections and reduce inappropriate antibiotic use particularly among lower and middle-income countries: findings and implications for the future Brian Godman, Mainul Haque, Judy McKimm, Current Medical Research and Opinion	2019	167
The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications Alessandra Ferrario, Diāna Arāja, Tomasz Bochenek, PharmacoEconomics	2017	117
Systemic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries Tomasz Bochenek, Vafa Abilova, Ali Alkan, Frontiers in Pharmacology	2018	102
Fixed dose drug combinations – are they pharmacoeconomically sound? Findings and implications especially for lower- and middle-income countries Brian Godman, Holly McCabe, Trudy Leong, Expert Review of Pharmacoeconomics & Outcomes Research	2020	86
Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications Brian Godman, Andrew Hill, Steven Simoens, Expert Review of Pharmacoeconomics & Outcomes Research	2021	71
Are pharmacists’ good knowledge and awareness on antibiotics taken for granted? The situation in Albania and future implications across countries Iris Hoxha, Admir Malaj, Besmira Kraja, Journal of Global Antimicrobial Resistance Preventive MedicineAntibioticsAntimicrobial StewardshipGlobal HealthPharmaceutical Practice	2018	68
The Expiry of Humira® Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures Evelien Moorkens, Brian Godman, Isabelle Huys, Frontiers in Pharmacology	2021	67
Antimicrobial Medicines Consumption in Eastern Europeand Central Asia – An Updated Cross-National Study and Assessment of QuantitativeMetrics for Policy Action Jane Robertson, Kotoji Iwamoto, Iris Hoxha, Frontiers in Pharmacology	2019	65

Page 1